Major academic publishers make billions of dollars:
Elsevier: $3.9 billion, Springer Nature: $2 billion, Wiley: $1.8 billion
As for peer reviewers, they are paid $0.
ReseachHub is a new online platform that pays peer reviewers up to $150 per review:
Rewild your gut: Fighting modern diseases w/ancient microbes
Preview of @CellCellPress work showing diet mimicking non-industrialized patterns (“Restore” diet) enhances L. reuteri & improves microbiome metabolites, leading to cardiometabolic benefits
https://t.co/Yckvh7NWNw
The GLP-1 receptor agonists (like Ozempic and Mounjaro) are wildly effective weight-loss agents. But are they COST-effective? That's a trickier question. And a new study just out in JAMA Health Forum provides an answer. A resounding "no."
(Thread)
How do viruses transform normal cells into cancer cells? With the help of a grant from the @AACR, Blossom Damania, PhD, has explored that question. Read more: https://t.co/Cz9eO6SxST @DamaniaLab#AACRGrants
A study led by researchers in the lab of Blossom Damania (@DamaniaLab), PhD, shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human protein to help the viruses evade innate immune detection to spread undeterred. https://t.co/mpXQhG5plo
A study led by @DamaniaLab researchers shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human protein to help the viruses evade innate immune detection to spread undeterred. https://t.co/mpXQhG5plo
Our story on the modulation of cGAS by KSHV and EBV is out in @NatureComms
Big congrats to my grad student, Grant @gsbrou ! Thanks also to our coauthors.@LabDittmer
Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation https://t.co/hzVRKNPzJ1
What % of people have had Covid?
3 reports in the last couple of weeks with different methods, population, timing
Range from 42 to 94%!
https://t.co/TQxPntYynP
https://t.co/rxerJQZy7J
https://t.co/BmKl4B4UwE
How do viruses transform normal cells into cancer cells? That's the question Blossom Damania, PhD, has sought to answer, with some help from the AACR. Read more: https://t.co/ZW55s1rlpD
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness, Nirsevimab for prevention of RSV infection in infants, severe Monkeypox in hospitalized patients, reinfections with SARS-CoV-2 Omicron subvariants and more https://t.co/HDkTfevAAW